Clinical Trial Update: A Randomized Trial of Docosahexaenoic Acid Supplementation During Pregnancy to Prevent Deep Placentation Disorders [Phase 3]

View source ↗

Summary

Phase 3 randomized trial evaluating whether DHA supplementation during pregnancy can prevent deep placentation disorders such as preterm birth and preeclampsia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fetal Growth Restriction
• Preeclampsia
• Preterm Birth
• Stillbirth

Drugs mentioned

• Docosahexaenoic acid (docosahexaenoic acid)

Snippet

Sponsor: Pontificia Universidad Catolica de Chile | Conditions: Premature Birth, Preeclampsia | Phase 3 | Status: UNKNOWN